Alzheimer's News -- ScienceDaily
3 days ago · Learn about Alzheimer's Disease symptoms such as memory loss and senile dementia. Find out about the treatments and causes, as well as the stages of Alzheimer's Disease and dementia.
With new therapies that promise to slow Alzheimer’s disease ... - CNN
Jul 16, 2023 · Under new draft guidelines for the diagnosis of Alzheimer’s disease, unveiled on Sunday at a large international gathering of physicians and researchers, these memory tests would take a...
Researchers have found a protein that seems to protect brain cells …
Jul 24, 2024 · A study of 48 post-mortem brains found a protein that appears to protect brain cells from Alzheimer's — even in people who had significant amounts of amyloid plaques in their brains.
Alzheimer’s disease may damage the brain in two phases
Oct 15, 2024 · Alzheimer’s disease may damage the brain in two distinct phases, based on new research funded by the National Institutes of Health (NIH) using sophisticated brain mapping tools.
Alzheimer's disease - Latest research and news | Nature
Oct 25, 2024 · Alzheimer's disease is a progressive neurodegenerative disease that impairs memory and cognitive judgment and is often accompanied by mood swings, disorientation and eventually delirium.
Rare cases of possible Alzheimer’s transmission uncovered in ... - CNN
Jan 29, 2024 · Early-onset dementia symptoms in five adults may be connected to a now-discontinued human growth hormone medical treatment that they received decades ago as children, a new study suggests. The...
New Treatment Reverses Alzheimer’s Disease Signs
Dec 20, 2023 · PHILADELPHIA – A “chaperone” molecule that slows the formation of certain proteins reversed disease signs, including memory impairment, in a mouse model of Alzheimer’s disease, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
First Alzheimer’s drug to slow disease progression gets full FDA ...
Jul 7, 2023 · The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease.
FDA fully approves Leqembi, first drug shown to slow Alzheimer's ...
Jul 6, 2023 · In studies reviewed by the FDA, Leqembi appeared to slow declines in memory and thinking by about 27% after 18 months of treatment. It also dramatically reduced the sticky beta-amyloid plaques...
Lilly's Alzheimer’s drug that can slow disease gets ... - NBC News
Jun 10, 2024 · A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with mild dementia...